ResearcherWashington University in St. LouisNo recent work listed

Faliang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8603-736X; OpenAlex author ID A5063081130. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor. Co-author DOI 10.3390/cancers13205076 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lin Li · 1 shared paper, 2021 · strength 0.16
- Paper Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the C… DOI 10.3390/cancers13205076 ↗
Paarth B. Dodhiawala · 1 shared paper, 2021 · strength 0.16
- Paper Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the C… DOI 10.3390/cancers13205076 ↗
Jieya Shao · 1 shared paper, 2021 · strength 0.16
- Paper Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the C… DOI 10.3390/cancers13205076 ↗
Kian‐Huat Lim · 1 shared paper, 2021 · strength 0.16
- Paper Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the C… DOI 10.3390/cancers13205076 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.